During the past decade, C.R.C. Beatson Laboratories conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "C.R.C. Beatson Laboratories" are "Unspecified Adult Solid Tumor, Protocol Specific" (5 trials), "Breast Cancer" (2 trials), "Lung Cancer" (2 trials), "Melanoma (Skin)" (1 trials) and "Myelodysplastic Syndromes" (1 trials). Many other conditions were trialed in "C.R.C. Beatson Laboratories" in a lesser frequency.

Most popular intervention types in "C.R.C. Beatson Laboratories" are "Drug" (8 trials), "Procedure" (3 trials), "Biological" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (2 trials), "docetaxel" (2 trials), "radiation therapy" (2 trials), "tamoxifen citrate" (2 trials) and "BIBX 1382" (1 trials). Other intervention names were less common.

The vast majority of trials in "C.R.C. Beatson Laboratories" are 7 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "C.R.C. Beatson Laboratories". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in C.R.C. Beatson Laboratories, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in C.R.C. Beatson Laboratories, 5 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".